baber/WOPTO huggingface dataset:
Patent SE-9504683-A0 (SE)
Title: Ångkraftanläggning enligt Carnot-principen, utnyttjande en energibärare med låg kokpunkt
Inventor: NILSSON CARL-EINAR
IPC: F01K25/10
Filed: 1995-12-28
Abstract: Sammandrag En angkraflanlaggning enligt Carnot-principen som anvander vatten som energibarare kan inte anvandas vid lagre temperatur an 100 °C (vid normalt lufttryck). Ett vardigt forfarande är att vattenangan bringas att kondensera for att sedan trycksattas med en matarvattenpump. Det trycksatta mediet blir sedan uppvarmt t.ex. med en laga i en fingpanna eller dylikt och fdringas darvid. Angan under Mgt tryck anvands sedan som en energikalla t.ex. i en Angturbin. FOr att kunna anvanda uppvarnming med lAga temperaturer (under 100 °C) kan man istallet for vatten anvanda en energibarare med lagre kokpunkt, t.ex. koldioxid. Vid ett tryck Over bar kan man kondensera koldioxidgasen till vatska. Kondensationstemperaturen är vid detta tryck ca -50 °C. Den kondenserade koldMxidvatskan kan nu trycksattas med en matarpump och uppvarmas pa sedvanligt satt. Man kan da anvanda en varmekalla av lagre temperatur an i exemplet med angkraftanlaggningen ovan. Del finns dock inget naturligt kylrnedium fbr kondensation vid -50 °C. Den Mr presenterade uppfinningen anvander istallet absorption av energibararen, t.ex. natriumhydroxid eller monoetanolamin for koldioxid. Den absorberade energibararen kan sedan trycksattas payedertaget satt och sedan desorberas innan den anvandes for energiutvinning i t.ex. en turbin. Eftersom absorption gynnas av lag temperatur kan t.ex. en varmepump anvandas for att sanka temperaturen i absorptionskarlet, respektive hdja temperaturen i desorptionskarlet.
Patent FI-20030715-A0 (FI)
Inventor: LEVOLA TAPANI
IPC: G02B6/126
Filed: 2003-05-13
Abstract: A method and optical system for coupling light from an incoming light wave (WI) into a waveguiding substrate (S) arranges the light wave (WI) to interact with a diffractive in-coupling grating element or elements (IG) arranged on or embedded within the substrate (S) and arranged to couple the energy from the light wave (WI) into a waveguided light wave (WG). The polarization state of the light wave (WI) is converted after its first interaction (D 1 ) with the in-coupling grating element/elements (IG) and before a second interaction (D 2 ) with the grating element/elements (IG) takes place. The method minimizes any "reverse" diffractions, which would direct light back towards the front-end optics and therefore to increase the width W of the in-coupling grating/gratings (IG). Preferred embodiments include diffractive beam expanders for virtual displays.
Patent FI-20075731-A0 (FI)
Inventor: JERNSTROEM EEVA
IPC: D21H/
Filed: 2007-10-17
Abstract: The invention relates to a method for making printing paper by forming the paper from a wood-containing raw material. According to the invention, the printing paper is formed by optimizing simultaneously the sensory properties of the printing paper, the quality of the printing paper and the cost-effectiveness of papermaking and/or printing, and at least one variable is adjusted, the variable being selected from the group of variables: the raw material composition of the printing paper, properties of the raw materials, modes of processing the raw materials, papermaking parameters and printing parameters.
Patent FI-20106063-A0 (FI)
Inventor: MELTAUS JOHANNA
IPC: H03H/
Filed: 2010-10-14
Abstract: The invention relates to an acoustically coupled thin-film BAW filter, comprising a piezoelectric layer, an input-port on the piezoelectric layer changing electrical signal into an acoustic wave (SAW, BAW), and an output-port on the piezoelectric layer changing acoustic signal into electrical signal. In accordance with the invention the ports include electrodes positioned close to each other, and the filter is designed to operate in first order thickness-extensional TE1 mode.
Patent IL-123776-A0 (IL)
Title: Novel derivatives of cyclodepsipeptide PF 1022
IPC: C07D273/00
Filed: 1996-09-20
Abstract: Novel derivatives of PF1022 substance, which are cyclodepsipeptides represented by the general formula (I) shown below or their salts are useful as anthelmintic agent for prevention or treatment of parasitic infections. <CHEM>
Patent IL-132599-A0 (IL)
Title: Substituted 3,3-diamino-2-propenenitriles their preparation and use
IPC: C07D213/40
Filed: 1998-05-06
Abstract: Substituted cyanoenamines of general formula (I) wherein Z, R<1>, R<2> and R<3> are defined in the description, compositions thereof and methods for preparing the compounds are described. The compounds are useful in the treatment of diseases of the central nervous system, the cardiovascular system, the pulmonary system, the gastrointestinal system and the endocrinological system.
Patent IL-137794-A0 (IL)
Title: Streptogramin derivatives, preparation method and compositions containing same
IPC: A61P31/04
Filed: 1999-02-24
Abstract: Group B streptogramin derivatives of general formula (I) are disclosed: wherein Ra, Rb, Rc, Rd, R<SUB>1</SUB>, R<SUB>2 </SUB>and Y are as defined in the description, including preparation methods and compositions containing the same. Such derivatives are particularly useful as antimicrobial agents, optionally combined with at least one group A streptogramin derivative.
Patent IL-139910-A0 (IL)
Title: Plastic films containing a fragrance and an odor barrier material within and method for their production
IPC: A61L9/04
Filed: 2000-11-26
Abstract: A plastic film comprised of a polymer material, fragrance, and a waxy chemical composition for imparting to the film substantial impermeability to odors. A method for producing such films including the steps of: adding a liquid fragrance to highly porous polymer pellets; adding a waxy chemical composition to the fragrance and polymer; blending the polymer, fragrance, and waxy composition mixture; adding additional polymer to the blended mixture; extruding the resultant composition, thereby forming pellets; mixing the pellets with additional polymer; and forming a film therefrom. A plastic film, produced according to this method, for packaging or for masking unpleasant odors, comprising polyethylene or polypropylene, a fragrance, and a bis fatty-acid amide is also disclosed.
Patent IL-148819-A0 (IL)
Title: Control group for directional fins on missiles and/or shells
IPC: F42B15/01
Filed: 2002-03-21
Abstract: A control group for directional fins on missiles and/or shells comprises a containment body (15, 15', 15'') carrying on the outside two command surfaces in the form of fin or half-fin surfaces (13, 14) which are hinged (at 24, 25), directable and motorised, in which the containment body (15, 15', 15'') foresees two housings (16) each of which receives an electric motor (17, 17') which commands, through a gear-dowm group (19, 29; 19', 29'), the oscillation about an axis (Z) of the control group of a pair of rings (21, 22), arranged in annular seats (31, 32) and in which end attachments (26) of the half-fins (13, 14) engage, the half-fins (13, 14) being hinged diametrally opposed in a further ring (20) arranged in an annular seat (23) of the containment body (15, 15', 15'') free to rotate about the axis (Z). <IMAGE>
Patent IL-149965-A0 (IL)
Title: An ink supply device for a four color modular printhead
IPC: B41J2/155
Filed: 2000-12-07
Abstract: A printhead is provided having an assembly of printhead modules. Each printhead module has a support defining fluid chambers, a fluid distributor on the support, and an integrated circuit on the distributor so that fluid in the chambers is distributed to the fluid ejection nozzles of the integrated circuit by the distributor. The support and distributor of each printhead module are shaped to define complementary formations on opposite sides of that printhead module so that the printhead modules are mated together in an angled fashion with the integrated circuits of the mated printhead modules abutting together and diagonally overlapping to define at least one row of fluid ejection nozzles of the printhead.
Patent IL-162646-A0 (IL)
Title: A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer
IPC: A61K33/32
Filed: 2003-01-13
Abstract: A nutrient pharmaceutical formulation composition useful for treating cancer comprising ascorbic acid, L-lysine, L-proline and at least one polyphenol compound selected from the group consisting of epigallocatechin gallate, epicatechin gallate, epigallocatechin, epicatechin, catechin and the use of the composition in treating cancer and other tumors are provided. A nutrient pharmaceutical formulation composition of EPICAN FORTE(TM) and its method of use in treating cancer are also disclosed.
Patent IL-180612-A0 (IL)
Title: Materials and methods for immune system stimulation
IPC: A61K31/716
Filed: 2007-01-09
Abstract: The subject invention concerns a novel polysaccharide. RR1 is an alpha-D-glucan polysaccharide composed of a (1->4) linked back bone and (1->6) linked branches, which has been isolated from a medicinal herb, Tinospora cordifolia. RR1 exhibits unique immune-stimulating properties, is non-cytotoxic, and non-proliferating to normal lymphocytes, as well as tumor cell lines. The subject invention also concerns compositions containing an RR1 compound and methods for modulating an immune response in a subject using RR1 compounds. The present invention also provides methods for the use of an RR1 compound in conjunction with an antigen to stimulate an immune response, the RR1 compound providing an adjuvant-like activity in the generation of a Th1-type immune response to the antigen.
Patent RO-132496-A0 (RO)
Title: Energy system and method for dimensioning the system
Inventor: RÂPAŞ ADRIAN
IPC: F03D3/02
Filed: 2017-10-03
Abstract: The invention relates to an energy system meant to produce electric energy and hydrogen for third parties, as well as to replace the currently used fossil-fuel-based polluting energy sources, when depleted, in 25-35 years, and to a method for dimensioning the system. According to the invention, the energy system consists of some pyramids (2) on which there are attached some cables (3), on which a tower (4) is mounted, at the middle of the tower there being mounted a basket (5) penetrated by the tower (4), which spins about the axis of the tower (4), fixing an airscrew (6) in the wind direction, which acts, through a by-pass shaft (29), thus, through a web of towers and cables, wind energy web, a high density of turbines is achieved to allow, due to the excess energy and the low price, the production of hydrogen, by electrolysis, the hydrogen being stored in some recipients, to be used for producing electric energy or to be delivered to third parties. The claimed system-dimensioning method consists in building some very high and resistant pyramids or prisms able to support some cables on which a number of wind turbines, adapted to the system, may be mounted on several levels, thus allowing the intensive use of the wind, and, on the other hand, if classic installations for decomposing water by electrolysis are built, appropriate recipients for storing hydrogen and oxygen, as well as electric generators driven by motors, they may operate with the energy resulted from the reaction of hydrogen with oxygen.
Patent RO-133606-A0 (RO)
Title: Installation for high-frequency cold-plasma treatments
Inventor: IOANID EMIL GHIOCEL
IPC: A61L2/00
Filed: 2019-04-22
Abstract: The invention relates to an installation for high-frequency cold-plasma treatments allowing decontamination and non-destructive cleaning of fragile objects belonging to cultural heritage, having complex geometry and a volume of up to 25 x 25 x 25 cm, using spatial-type afterglow plasma, the installation being meant for preserving-restoration laboratories in museums, libraries and archives. According to the invention, the installation consists of a cylindrical reaction vessel (1) sealed by means of two electrode-flanges (2 and 3), with a detachable module (M) placed inside, on which there are two electrodes (24 and 25) made of stainless steel mesh, an annular frame (19) for fixing the object (23), where the electrodes (24 and 25) are capacitively coupled to a high-frequency generator (31) of 13.5 MHz which generates an active plasma (b and c) between the pairs of electrodes (2-24 and 3-25) and, by overlapping the flows of reactive particles diffused from the active plasma, a spatial-type homogeneous afterglow plasma (d) is formed between the electrodes (24 and 25).
Patent AP-2002002418-A0 (AP)
Title: Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins.
Inventor: CHEN YAN
IPC: C12R/
Filed: 2000-07-24
Abstract: The present invention relates to polynucleotide molecules comprising nucleotide sequences encoding an avec gene product, which polynucleotide molecules can be used to alter the ratio or amount of class 2:1 avermectins produced in fermentation cultures of s. Avermitilis. The present invention further relates to vectors, host cells, and mutant strains of s. Avermitilis in which the avec gene has been inactivated, or mutated so as to change the ratio or amunt of class 2:1 avermectins produced.
Patent AU-2002951326-A0 (AU)
Title: Communication apparatus and helmet
IPC: H04B1/38
Filed: 2002-09-11
Abstract: A communication apparatus includes a support structure (41) that is fastenable to a safety helmet (58). A vibration conduction microphone (54) is carried by the support structure. The vibration conduction microphone and the speaker enclosure (43) are positioned so that, when the support structure is fastened to the safety helmet, the vibration conduction microphone and the speaker enclosure come into contact with a rear of the wearer's head.
Patent IE-910288-A1 (IE)
Title: Stabilized cultures of microorganisms
Inventor: KING ANDREW BRIAN
IPC: A23K3/03
Filed: 1991-01-28
Abstract: PCT No. PCT/GB91/00116 Sec. 371 Date Sep. 29, 1992 Sec. 102(e) Date Sep. 29, 1992 PCT Filed Jan. 28, 1991 PCT Pub. No. WO91/11509 PCT Pub. Date Aug. 8, 1991Cultures of microorganisms, particularly in freeze dried form, include an ascorbic acid antioxidant and a monocarboxylic  alpha -amino acid each of which are present at a mass fraction of 0.05 to 0.3. The acid acts as a potentiator for the antioxidant. The cultures are more stable for extended storage, particularly at relatively high temperatures, than unstabilized cultures. Further, additional components include a carbohydrate in an amount of 25 to 45 weight percent, particularly inositol or sucrose, a viscosity inducer and a cryoprotectant. The latter two need not be different materials to the carbohydrate. The invention is suitable for stabilizing cultures of microorganisms such as lactic acid producing strains of Lactobacillus or Streptococcus; and the cultures are useful as additives and forage, especially silage.
Patent MA-21405-A1 (MA)
Inventor: GIOVANNI PIETRO CASTIGLIONI
IPC: B21D43/09
Filed: 1988-10-14
Abstract: An apparatus for the correct feeding of continuous strips (11) with a shaped side outline to blanking or pressing machines, such as presses, by means of which the continuous strip, unwinding from a roll, can be feed in a position of perfect trueing under the die of the blanking machine, thanks to the presence of a control and of a continuous correction of the positioning errors caused by stresses, or a non-perfect axiality in the fed strip. The strip (11) is fed by a pair of rolls (24,27) one being motor-driven and operatively connected to sensor elements (23) detecting the change in the shaped side outline of the strip.
Patent MA-26954-A1 (MA)
Title: ALPHA-ARYLETHANOLAMINES ET LEUR UTILISATION COMME AGONISTES DES RECEPTEURS BeTA3-ADRENERGIQUES
Inventor: ROBERT FRANCIS DAY
IPC: C07D409/14
Filed: 2003-04-15
Abstract: DEPOSANT Société dite : PFIZER PRODUCTS INC. REVENDICATION DE PRIORITES US 20 Octobre 2000 60/242,274 Voir en annexe le titre de l'invention et le texte de l'abrégé Alpha-aryléthanolamines et leur utilisation comme agonistes des récepteurs bêta3-adrénergiques La présente invention propose des agonistes des récepteurs bêta3-adrénergiques de formule structurale (I), dans laquelle Ar représente un groupe pyridyle, oxazolyle, thiazolyle ou phényle ; R5 représente un hétérocycle penta-ou hexagonal ; X représente une liaison directe ou un atome d'oxygène ; et Y représente une liaison directe, un groupe alkylène, OCH2,- CH2O ou un atome d'oxygène ; leurs stéréoisomères et précurseurs médicamenteux, et les sels pharmaceutiquement acceptables des composés, stéréoisomères et précurseurs médicamenteux. La présente invention propose en outre des intermédiaires utiles dans la préparation des composés de formule (I) , et des associations des composés de formule (I) , de leurs stéréoisomères et précurseurs médicamenteux, et des sels pharmaceutiquement acceptables des composés, stéréoisomères et précurseurs médicamenteux, avec des agents anti-obésité.
Patent MA-28058-A1 (MA)
Title: Hangar préfabriqué en béton
Inventor: JUAN MUNTAL TRAVERIA
Filed: 2005-01-24
Abstract: HANGAR PREFABRIQUE EN BETON L'hangar préfabriqué en béton, est caractérisé par être formé à base de: piliers en béton armé avec armature de 4 à 25mm, de 2 à 50 m d'hauteur, de 25X25 à 70X70cm de section, avec son extrémité supérieur fini plan, en forme de descente ou en forme de « L », que peuvent incorporer de 1 à 10 goussets dans 1 et/ou dans n'importe quel des quatre faces, avec emboîtements dans 1 et/ou dans n'importe quel des quatre faces pour l'assemblage des murs. De poutre maîtresse en béton armé avec armature de 4 à 25mm, relevés ou non et de 2 à 40m de longueur. Jambes de force en béton armé avec armature de 4 à 25mm et de 2 à 40m de longueur. Cintre en béton armé avec armature de 4 à 25mm et de 5 à 40m de longueur. Portails en béton armé avec armature de 4 à 25mm avec hauteur de 2 à 20m et de 5 à 50m de lumière. Murs en béton armé avec armature de 4 à 25mm, de 4 à 25cm d'épaisseur et d'1 à 15m de longueur compactes ou avec plaques en polystyrène étendu dans son intérieur et finis fins ou grattés. Descente de récolte des eaux en béton armé avec armature de 4 à 25 mm et de 2 à 40m de longueur. L'hangar préfabriqué en béton est destiné à la construction de bâtiments industriels, usines, dépôts, fermes, et n'importe quel autre genre d'édification similaire, moyennant le système de modules préfabriqués.
Patent MA-49541-A1 (MA)
Title: Cuvette de toilette pivotante et dissimulable
Inventor: EL MAJID BADRE
IPC: E03D11/12
Filed: 2020-04-20
Abstract: L'invention concerne un système de toilettes cachées comprenant une cuvette de forme conique, la cuvette inférieure est de forme concave dans laquelle les déchets sont collectés et ensuite déchargés dans un réservoir à déchets. La cuvette est disposée de manière rotative sur un axe de pivotement pour avoir deux modes de fonctionnement : « en service » et « « fermé ». Le premier mode pour une éventuelle utilisation de des toilettes ; et le deuxième mode pour libérer l'espace pour d'autres utilisations. Surtout dans les moyens de transport tels que les avions, les bateaux, les bus et tous autres types de véhicules de transport, où l’espace est très important vu leur surface limitée. Le système est également composé d'un réservoir d'eau de drainage collecté dans le lavabo afin d'économiser l'eau. Le système est équipé d'injecteurs et d’une lampe ultraviolette (uv) pour la désinfection et le nettoyage des toilettes à l'intérieur de l'unité structurelle.
Patent MA-51924-A1 (MA)
Title: Dispositif de protection d’un examen ophtalmologique en lampe à fente.
Inventor: AIT RAHHOU AISSA
IPC: A61B3/00
Filed: 2020-11-30
Abstract: Au cours des consultations ophtalmologiques et particulièrement lors de l’examen en lampe à fente, la distance rapprochée entre le médecin et le patient constitue une situation à risque aussi bien pour l’un que pour l’autre. La présente invention propose un dispositif médical de protection des ophtalmologues tout en apportant plus de sécurité en isolant le patient et l’ophtalmologiste, sans gêner l’examen physique que doit faire le médecin. Ledit dispositif de protection d’un examen ophtalmologique en lampe à fente comprenant : un écran principal transparent (3) en plexiglass en forme d’arc fixé sur un ruban en plastique (4) incurvé concave, une membrane (6) d’une section généralement circulaire dont la fibre neutre est composée de deux lignes verticales parallèles interconnectées par un arc horizontal, deux sangles (8) caractérisé en ce que la membrane (6) comporte une rainure ou une fente s'étendant le long de la membrane et configurée pour former une butée du ruban en plastique (4) , ce dernier étant destiné à être inséré dans la fente jusqu'à ce que le bord supérieur bute contre la paroi intérieure de la membrane ce dispositif de protection d’ophtalmologiste prend une forme courbée devant le visage du patient en couvrant le nez jusqu’au menton et laissant les yeux couverts pour permettre à l’ophtalmologiste de les examiner.
Patent UY-24580-A1 (UY)
Title: Nuevos compuestos de imidazol sustituidos
Inventor: JERRY L ADAMS
IPC: A61P11/06
Filed: 1997-06-10
Abstract: Es objeto de la presente invención un procedimiento para preparar un compuesto representado por la fórmula (I) (figura 1) en la que R1 es un anillo de 4-piridilo o 4-pirimidinilo, que está sustituido; R4 es fenilo, naft-1-ilo o naft-2-ilo, o un heteroarilo que opcionalmente está sustituido; R2 es 1-fenil-4-piperidina, entre otros; Z es oxígeno o azufre; Rc es heterociclilo, entre otros; R3 es heterociclilo, entre otros; R7 y R17 conjuntamente con el nitrógeno al que están unidos, forman un anillo heterocíclico de 5 a 7 miembros, el cual contiene opcionalmente un heteroátomo adicional seleccionado de oxígeno, azufre o NR15. Como ejemplo no limitante: 5-(2-metoxi-4-pirimidinil)-4-(4-fluorofenil)-1-(4-piperidinil)imidazol. Se describle también el proceso para su preparación y su uso en el tratamiento de enfermedades mediadas por IL-1, IL-6, IL-8 ó TNF, como asma, osteoporosis y artritis.
Patent UY-25821-A1 (UY)
Title: Preparaciones de una combinación farmacéutica de carvedilol e hidroclorotiazida
Inventor: HELLER RUDOLF
IPC: A61K31/54
Filed: 1999-11-26
Abstract: La presente invención se refiere a una preparación de una combinación farmacéutica para el tratamiento de trastornos cardíacos y cardiovasculares tales como hipertensión, angina de pecho, insuficiencia cardíaca y enfermedades relacionadas, que contiene las substancias activas carvedilol o una sal farmacéuticamente aceptable del mismo e hidroclorotiazida o una sal farmacéuticamente aceptable de la misma, así como aditivos usuales farmacéuticamente. El proceso de producción para la preparación de la combninación, puede comprender los pasos de producción del granulado de carvedilol, de hidroclorotiazida, tratamiento de ambos granulados hasta obtener una masa prensada con una humedad de 6 a20% y una densidad de granel entre 0.1 y 1.5 g/ml
Patent UY-26830-A1 (UY)
Inventor: REGIS LE COUEDIC
IPC: A61F2/46
Filed: 2001-07-11
Abstract: The invention provides an intersomatic implant suitable for containing at least one bone graft and for being inserted in the intervertebral space along a predetermined direction. It comprises: a first portion (10) of generally annular shape surrounding an aperture (11) and presenting a top first edge (12) and a bottom first edge (14); and a second portion (16) of elongate shape along its main axis (A) presenting a bottom second edge (18) and a top second edge (20), and interconnecting two facing opposite regions of said first portion (10) along said predetermined direction, thereby dividing said aperture (11) into two housings suitable for containing said bone graft, at least one of said bottom and top second edges projecting from the space defined by said bottom and top first edges (14, 12) of the first portion (10).